share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer O'Hara Elaine

SEC announcement ·  Mar 5 19:34
Summary by Moomoo AI
On March 1, 2024, Elaine O'Hara, EVP and Chief Strategy Officer of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. O'Hara acquired 19,600 shares at a price of $5.39 per share through the exercise of derivative securities. On the same day, she disposed of 5,375 shares at the same price, which was related to the payment of exercise price or tax liability by delivering or withholding securities. After these transactions, O'Hara's direct holdings in Novavax common stock amounted to 14,225 shares. The total market value of the disposed shares was calculated to be $28,971.25.
On March 1, 2024, Elaine O'Hara, EVP and Chief Strategy Officer of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. O'Hara acquired 19,600 shares at a price of $5.39 per share through the exercise of derivative securities. On the same day, she disposed of 5,375 shares at the same price, which was related to the payment of exercise price or tax liability by delivering or withholding securities. After these transactions, O'Hara's direct holdings in Novavax common stock amounted to 14,225 shares. The total market value of the disposed shares was calculated to be $28,971.25.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more